JULIANA CACERES: Open Payments
NPI 1053958579 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 45 payments from 15 companies in 2025. Trend: 2023 $710 · 2024 $540 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $204 |
| Lilly USA, LLC | 10 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Amgen Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| SI-BONE, INC. | 1 | $26 |
| Exact Sciences Corporation | 1 | $24 |
Products named: MOUNJARO, Wegovy, Ozempic, Kerendia, JARDIANCE, SHINGRIX, EVENITY, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
